AVNS
Income statement / Annual
Last year (2023), Avanos Medical, Inc.'s total revenue was $673.30 M,
a decrease of 17.89% from the previous year.
In 2023, Avanos Medical, Inc.'s net income was -$61.80 M.
See Avanos Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$673.30 M
|
$820.00 M
|
$744.60 M
|
$714.80 M
|
$697.60 M
|
$652.30 M
|
$611.60 M
|
$1.59 B
|
$1.57 B
|
$1.67 B
|
| Cost of Revenue |
$293.60 M |
$370.00 M |
$380.30 M |
$341.50 M |
$295.40 M |
$261.40 M |
$274.70 M |
$1.03 B |
$1.04 B |
$1.12 B |
| Gross Profit |
$379.70 M |
$450.00 M |
$364.30 M |
$373.30 M |
$402.20 M |
$390.90 M |
$336.90 M |
$557.90 M |
$531.60 M |
$548.60 M |
| Gross Profit Ratio |
0.56 |
0.55 |
0.49 |
0.52 |
0.58 |
0.6 |
0.55 |
0.35 |
0.34 |
0.33 |
| Research and Development
Expenses |
$27.20 M
|
$30.60 M
|
$32.30 M
|
$34.90 M
|
$37.70 M
|
$41.80 M
|
$38.20 M
|
$41.10 M
|
$32.30 M
|
$33.60 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$340.40 M
|
$321.70 M
|
$411.10 M
|
$398.50 M
|
$424.50 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$318.10 M
|
$341.90 M
|
$300.30 M
|
$332.60 M
|
$399.10 M
|
$340.40 M
|
$321.70 M
|
$411.10 M
|
$398.50 M
|
$424.50 M
|
| Other Expenses |
$0.00 |
$3.50 M |
$22.80 M |
$51.90 M |
$21.10 M |
$8.20 M |
$20.10 M |
$18.30 M |
$4.50 M |
-$3.80 M |
| Operating Expenses |
$375.50 M |
$376.00 M |
$355.40 M |
$419.40 M |
$457.90 M |
$390.40 M |
$380.00 M |
$470.50 M |
$435.30 M |
$454.30 M |
| Cost And Expenses |
$669.10 M |
$746.00 M |
$735.70 M |
$760.90 M |
$753.30 M |
$651.80 M |
$654.70 M |
$1.50 B |
$1.48 B |
$1.58 B |
| Interest Income |
$2.90 M |
$1.20 M |
$200,000.00 |
$1.20 M |
$6.70 M |
$7.80 M |
$2.50 M |
$600,000.00 |
$300,000.00 |
$2.90 M |
| Interest Expense |
$15.00 M |
$10.00 M |
$3.30 M |
$15.60 M |
$15.00 M |
$26.40 M |
$31.60 M |
$32.70 M |
$33.10 M |
$6.00 M |
| Depreciation &
Amortization |
$46.10 M
|
$41.10 M
|
$38.30 M
|
$42.90 M
|
$36.90 M
|
$33.50 M
|
$40.00 M
|
$41.00 M
|
$65.40 M
|
$85.40 M
|
| EBITDA |
$53.20 M
|
$77.80 M
|
$8.90 M
|
-$2.00 M
|
-$12.10 M
|
$65.70 M
|
-$600,000.00
|
-$65.50 M
|
-$76.50 M
|
$179.70 M
|
| EBITDA Ratio |
0.08 |
0.15 |
0.06 |
-0 |
-0.02 |
0.06 |
0.03 |
0.1 |
0.1 |
0.11 |
| Operating Income Ratio
|
0.01
|
0.09
|
0.01
|
-0.06
|
-0.08
|
0
|
-0.07
|
0.05
|
-0.24
|
0.06
|
| Total Other
Income/Expenses Net |
-$12.10 M
|
-$8.80 M
|
$44.80 M
|
-$14.40 M
|
-$8.30 M
|
-$18.60 M
|
-$29.10 M
|
-$32.10 M
|
-$274.80 M
|
-$3.10 M
|
| Income Before Tax |
-$7.90 M |
$65.20 M |
$5.80 M |
-$60.50 M |
-$64.00 M |
-$18.10 M |
-$72.20 M |
$55.30 M |
-$410.50 M |
$91.20 M |
| Income Before Tax Ratio
|
-0.01
|
0.08
|
0.01
|
-0.08
|
-0.09
|
-0.03
|
-0.12
|
0.03
|
-0.26
|
0.05
|
| Income Tax Expense |
$2.00 M |
$14.70 M |
$600,000.00 |
-$33.30 M |
-$18.10 M |
-$9.60 M |
-$40.10 M |
$15.50 M |
$15.80 M |
$64.10 M |
| Net Income |
-$61.80 M |
$50.50 M |
$6.30 M |
-$27.20 M |
-$45.90 M |
$57.50 M |
$79.30 M |
$39.80 M |
-$426.30 M |
$27.10 M |
| Net Income Ratio |
-0.09 |
0.06 |
0.01 |
-0.04 |
-0.07 |
0.09 |
0.13 |
0.02 |
-0.27 |
0.02 |
| EPS |
-1.33 |
1.08 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
-9.15 |
0.58 |
| EPS Diluted |
-1.33 |
1.07 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
-9.15 |
0.58 |
| Weighted Average Shares
Out |
$46.60 M
|
$46.90 M
|
$48.10 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.52 M
|
$46.60 M
|
$46.59 M
|
$46.54 M
|
| Weighted Average Shares
Out Diluted |
$46.60 M
|
$47.30 M
|
$48.60 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.80 M
|
$47.00 M
|
$46.59 M
|
$46.54 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
